This September, learn more about the breakthroughs in neuropsychiatric drug development and immerse yourself in the forefront of innovation as we unite the sharpest industry minds shaping the field.
Browse the Full Event Guide to Discover:
1.
Explore the latest breakthroughs in muscarinics, digital therapeutics, non-hallucinogenic neuroplastogens and more
2.
Deep dive into the value of EEGs as translational tools in neuropsychiatry & beyond
3.
Navigate evolving regulatory hurdles in an era of growing potential for psychedelic drug approvals
4.
Pinpoint next-generation targets with minimal side effects using innovative symptom and circuit-based methodologies
5.
Advance the “gold standard” endpoint beyond subjective mood scales and strive for alignment with regulators on selected endpoints in trial design
Having trouble downloading the brochure? Let us know here and we’ll email it to you instead
Browse the Event Guide for Exclusive Insights from the Likes Of:
Discover Additional New & Unpublished Data at
the Scientific Poster Session:
A Snapshot of Last Year’s Submissions:
Structure-activity of 2C-X psychedelics to Develop a Novel 5-HT2A Receptor Full Agonist with Therapeutic Potential
Digital Precision Medicine: How real-time patient monitoring and personalized support can improve Adherence and Outcomes
Development of a BRET biosensor-based screening strategy for identifying drivers of hallucinogenic activity of 5HT2AR targeting compounds
Development of a Novel Drug Discovery Platform for Rapid Identification of Small Molecule CNS Therapeutics
Want to learn more about how you can submit a poster?
Get in touch to find out more
